Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone.
about
Therapy Effects of Bone Marrow Stromal Cells on Ischemic StrokePoststroke Cell Therapy of the Aged BrainThe Dark Side of the Force - Constraints and Complications of Cell Therapies for StrokeInvolvement of calpains in adult neurogenesis: implications for stroke.Transplantation of mesenchymal stem cells reverses behavioural deficits and impaired neurogenesis caused by prenatal exposure to valproic acid.Stem cell therapies in preclinical models of stroke associated with agingA possible new focus for stroke treatment - migrating stem cellsGranulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysis.Autologous Bone Marrow Mononuclear Cells Exert Broad Effects on Short- and Long-Term Biological and Functional Outcomes in Rodents with Intracerebral Hemorrhage.Effects of the combined treatment of bone marrow stromal cells with mild exercise and thyroid hormone on brain damage and apoptosis in a mouse focal cerebral ischemia model.Translating G-CSF as an Adjunct Therapy to Stem Cell Transplantation for Stroke.G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury.Translational Hurdles in Stroke Recovery Studies.Stem Cell-Based Therapies for Ischemic Stroke: Preclinical Results and the Potential of Imaging-Assisted Evaluation of Donor Cell Fate and Mechanisms of Brain Regeneration.Transient but not permanent benefit of neuronal progenitor cell therapy after traumatic brain injury: potential causes and translational consequences.Caloric restriction stabilizes body weight and accelerates behavioral recovery in aged rats after focal ischemia.Therapeutic potential of mesenchymal stromal cells for hypoxic ischemic encephalopathy: A systematic review and meta-analysis of preclinical studies.Bone Marrow Stromal Cells Combined With Sodium Ferulate and n-Butylidenephthalide Promote the Effect of Therapeutic Angiogenesis via Advancing Astrocyte-Derived Trophic Factors After Ischemic Stroke.Cellular and Molecular Mechanisms Underlying Non-Pharmaceutical Ischemic Stroke Therapy in Aged Subjects.New GABAergic Neurogenesis in the Hippocampal CA1 Region of a Gerbil Model of Long-Term Survival after Transient Cerebral Ischemic Injury.Enhancing endogenous capacity to repair a stroke-damaged brain: An evolving field for stroke research.Stem Cell Therapy and Administration Routes After Stroke.Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke.Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injuryMechanisms underlying dental-derived stem cell-mediated neurorestoration in neurodegenerative disordersMulticellular Crosstalk Between Exosomes and the Neurovascular Unit After Cerebral Ischemia. Therapeutic Implications
P2860
Q26749052-CC6B7B85-4692-4A64-9500-FBBFC126C542Q26782735-A2A5C778-48A3-48D2-B638-BF300417CE12Q26800181-81F9170E-84EF-4446-8E02-B5D0185FF8D2Q30300686-ABA6FCAE-6ED9-4390-AE8C-7979E51D4EF4Q33566524-6D66B8EB-3042-4B11-947B-ED9A3E91A1B3Q34442610-D0A2F74E-539D-4E1A-9304-2765A62293AFQ35738018-5D9AD7EB-B782-4417-A3A5-13DEB7115834Q36192434-DE8CBC72-A421-4E90-95E2-04B7DDF43AF4Q36301669-C5341EA3-FB31-4FEC-BFCF-7E184404595BQ36382301-8D1B9493-AB2C-49D4-9816-F1ABD641BF5AQ36522091-B04CE674-626C-47CD-8A68-FD58BBC7E4DBQ38342285-B3A32273-D420-4F2F-8244-37B189205684Q38783958-C636B515-5E1A-4FD7-8252-B63CB554188CQ38903653-DDA46579-F989-48B7-A7B0-048D5F58D65EQ41810795-AC294B91-3BE4-42E5-AE2F-59826F1C033AQ46727180-15ED0DC7-0481-418E-AD40-1E59798F2CCFQ47102184-CA460B5B-556E-4FA2-A02E-EDE6447FDC70Q47153068-4BFFBDA4-6BAE-48FC-A9FA-146F7BF50268Q47891295-34A6000C-0A28-4228-8661-1EE6CB6D128EQ50552616-735C5C71-C2AA-47D7-AD55-C951D856D99EQ51767535-B1C0B2FF-DD0C-4BC1-A09A-37795093E9A4Q54015446-A35D37A2-5C04-43AB-B007-1E30EF8AA57AQ55618499-2EC144E9-8477-4340-BC49-8D38CDE67234Q57153034-E04C8A4A-76A5-40BD-9D71-411BD118AAA1Q58695199-3333683C-EC56-44F9-A25B-1008380E3188Q59136421-204491F1-2625-4BD4-9A84-3D291E2ED191
P2860
Multimodal Approaches for Regenerative Stroke Therapies: Combination of Granulocyte Colony-Stimulating Factor with Bone Marrow Mesenchymal Stem Cells is Not Superior to G-CSF Alone.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Multimodal Approaches for Rege ...... s Not Superior to G-CSF Alone.
@ast
Multimodal Approaches for Rege ...... s Not Superior to G-CSF Alone.
@en
type
label
Multimodal Approaches for Rege ...... s Not Superior to G-CSF Alone.
@ast
Multimodal Approaches for Rege ...... s Not Superior to G-CSF Alone.
@en
prefLabel
Multimodal Approaches for Rege ...... s Not Superior to G-CSF Alone.
@ast
Multimodal Approaches for Rege ...... s Not Superior to G-CSF Alone.
@en
P2093
P2860
P356
P1476
Multimodal Approaches for Rege ...... is Not Superior to G-CSF Alone
@en
P2093
Adrian Tudor Balseanu
Ana-Maria Buga
Aurel Popa-Wagner
Daniel-Christoph Wagner
Johannes Boltze
Klaus Reymann
Wolf Schaebitz
P2860
P356
10.3389/FNAGI.2014.00130
P577
2014-06-23T00:00:00Z